Hyperkalemia in chronic peritoneal dialysis patients

Background. Chronic peritoneal dialysis (PD) patients often develop hypokalemia but less commonly hyperkalemia. Methods. We explored incidence and mechanisms of hyperkalemia in 779 serum samples from 33 patients on PD for 1 − 59 months. Normal serum potassium concentration was defined as 3.5 − 5.1 m...

Full description

Bibliographic Details
Main Authors: Andrew B. Elliott, Karim M. M. Soliman, Michael E. Ullian
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Renal Failure
Subjects:
Online Access:http://dx.doi.org/10.1080/0886022X.2022.2032151
_version_ 1818320761545293824
author Andrew B. Elliott
Karim M. M. Soliman
Michael E. Ullian
author_facet Andrew B. Elliott
Karim M. M. Soliman
Michael E. Ullian
author_sort Andrew B. Elliott
collection DOAJ
description Background. Chronic peritoneal dialysis (PD) patients often develop hypokalemia but less commonly hyperkalemia. Methods. We explored incidence and mechanisms of hyperkalemia in 779 serum samples from 33 patients on PD for 1 − 59 months. Normal serum potassium concentration was defined as 3.5 − 5.1 meq/l. Results. Mean monthly serum potassium concentrations were normal (except for 1 month), but we observed hypokalemia (<3.5 meq/l) in 5% and hyperkalemia (>5.1 meq/l) in 14% of 779 serum samples. Incidence of hyperkalemia did not change over time on PD: Year 1 (15%), Year 2 (11%), Year 3 (19%), Years 4–5 (22%). Hyperkalemia was mostly modest but occasionally extreme [5.2–5.4 meq/l (55%), 5.5–5.7 meq/l (21%), 5.8–6.0 meq/l (10%), >6.0 meq/l (14%)]. Of 31 patients (2 excluded due to brief PD time), 39% displayed hyperkalemia only, 23% displayed hypokalemia only, and the remainder (38%) displayed both or neither. Comparing hypokalemia-only with hyperkalemia-only patients, we found no difference in potassium chloride therapy, medications interrupting the renin-angiotensin system, small-molecule transport status, and renal urea clearance. We compared biochemical parameters from the hypokalemic and hyperkalemic serum samples and observed lower bicarbonate concentrations, higher creatinine concentrations, and higher urea nitrogen concentrations in the hyperkalemic samples (p < 0.001 for each), without difference in glucose concentrations. Conclusion. We observed hyperkalemia 3 times as frequently as hypokalemia in our PD population. High-potassium diet, PD noncompliance, increased muscle mass, potassium shifts, and/or the daytime period without PD might contribute to hyperkalemia.
first_indexed 2024-12-13T10:30:09Z
format Article
id doaj.art-51a280837a0e4df6ac8372eef37c6a91
institution Directory Open Access Journal
issn 0886-022X
1525-6049
language English
last_indexed 2024-12-13T10:30:09Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj.art-51a280837a0e4df6ac8372eef37c6a912022-12-21T23:50:53ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492022-12-0144121722310.1080/0886022X.2022.20321512032151Hyperkalemia in chronic peritoneal dialysis patientsAndrew B. Elliott0Karim M. M. Soliman1Michael E. Ullian2Division of Nephrology, Department of Medicine, Medical University of South CarolinaDivision of Nephrology, Department of Medicine, Medical University of South CarolinaDivision of Nephrology, Department of Medicine, Medical University of South CarolinaBackground. Chronic peritoneal dialysis (PD) patients often develop hypokalemia but less commonly hyperkalemia. Methods. We explored incidence and mechanisms of hyperkalemia in 779 serum samples from 33 patients on PD for 1 − 59 months. Normal serum potassium concentration was defined as 3.5 − 5.1 meq/l. Results. Mean monthly serum potassium concentrations were normal (except for 1 month), but we observed hypokalemia (<3.5 meq/l) in 5% and hyperkalemia (>5.1 meq/l) in 14% of 779 serum samples. Incidence of hyperkalemia did not change over time on PD: Year 1 (15%), Year 2 (11%), Year 3 (19%), Years 4–5 (22%). Hyperkalemia was mostly modest but occasionally extreme [5.2–5.4 meq/l (55%), 5.5–5.7 meq/l (21%), 5.8–6.0 meq/l (10%), >6.0 meq/l (14%)]. Of 31 patients (2 excluded due to brief PD time), 39% displayed hyperkalemia only, 23% displayed hypokalemia only, and the remainder (38%) displayed both or neither. Comparing hypokalemia-only with hyperkalemia-only patients, we found no difference in potassium chloride therapy, medications interrupting the renin-angiotensin system, small-molecule transport status, and renal urea clearance. We compared biochemical parameters from the hypokalemic and hyperkalemic serum samples and observed lower bicarbonate concentrations, higher creatinine concentrations, and higher urea nitrogen concentrations in the hyperkalemic samples (p < 0.001 for each), without difference in glucose concentrations. Conclusion. We observed hyperkalemia 3 times as frequently as hypokalemia in our PD population. High-potassium diet, PD noncompliance, increased muscle mass, potassium shifts, and/or the daytime period without PD might contribute to hyperkalemia.http://dx.doi.org/10.1080/0886022X.2022.2032151peritoneal dialysishyperkalemiahypokalemia
spellingShingle Andrew B. Elliott
Karim M. M. Soliman
Michael E. Ullian
Hyperkalemia in chronic peritoneal dialysis patients
Renal Failure
peritoneal dialysis
hyperkalemia
hypokalemia
title Hyperkalemia in chronic peritoneal dialysis patients
title_full Hyperkalemia in chronic peritoneal dialysis patients
title_fullStr Hyperkalemia in chronic peritoneal dialysis patients
title_full_unstemmed Hyperkalemia in chronic peritoneal dialysis patients
title_short Hyperkalemia in chronic peritoneal dialysis patients
title_sort hyperkalemia in chronic peritoneal dialysis patients
topic peritoneal dialysis
hyperkalemia
hypokalemia
url http://dx.doi.org/10.1080/0886022X.2022.2032151
work_keys_str_mv AT andrewbelliott hyperkalemiainchronicperitonealdialysispatients
AT karimmmsoliman hyperkalemiainchronicperitonealdialysispatients
AT michaeleullian hyperkalemiainchronicperitonealdialysispatients